"This new laser with yellow light is currently the only one of its caliber in the U.S., and there's only one other being used in the world right now," said Quan Dong Nguyen, M.D., the McGaw Memorial Endowed Chair in Ophthalmology and the director of the Truhlsen Eye Institute.
On July 22, the first patient received treatment from the laser for proliferative diabetic retinopathy, the most severe stage of eye disease caused by diabetes.
"Overall, it is more effective, efficient and may be safer than traditional lasers." Diana Do, M.D.
Diana Do, M.D.
Dr. Do was the retina specialist who performed the first treatment.
"It allows us to apply a large number of laser spots in a variety of patterns. Overall, it is more effective, efficient and may be safer than traditional lasers," she said.
Traditional lasers are limited in the number of patterns and pulsing they can accommodate, whereas the new laser allows for more nuanced and problem-specific targeting, Dr. Do said.
The laser provides treatment for various rare eye diseases, including retinal vein occlusion, neovascular glaucoma, and retinal tears. In addition, with micropulse application capability, it also can be combined with other therapies to treat diabetic macular edema, the most common cause of moderate vision loss for diabetes patients.
"With diabetes rates on the rise nationally and in Nebraska, more and more patients will be able to benefit from the superior treatment that new technology like this can bring," Dr. Do said.
The full name of the laser is the Supra Scan Multi-spot Laser. It is manufactured by Quantel Medical, which is headquartered in Paris, France.
The Truhlsen Eye Institute, which opened in June 2013 at 3902 Leavenworth St., is the newest building on UNMC's campus, and offers state-of-the-art eye care in many eye subspecialties as well as routine prescription and optical shop services. To make an appointment at the Truhlsen Eye Institute, please call 402-559-2020.
This is exciting! It's another prime example of how UNMC is always striving to be on the cutting edge of medicine and technology.